Home
Clinical Trials
Sisomicin Cream Vs Nadifloxac...

Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

NCT ID: NCT00202891

Last Updated: 2015-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2007-05-31

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This open-label, randomized, parallel-group clinical study is designed to compare the efficacy and safety of the topical antibiotic, sisomicin cream, with that of another topical antibiotic cream, nadifloxacin cream, in the treatment of Indian patients with primary pyodermas.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections

NCT01184872

Infections

COMPLETED PHASE3

Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

NCT00426933

Soft Tissue Infections

COMPLETED PHASE2

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

NCT00516958

Foot Ulcer, Diabetic

COMPLETED PHASE2

Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting

NCT01175707

Complicated Skin or Skin Structure Infection

TERMINATED PHASE4

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

NCT00102947

Soft Tissue Infections

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pyoderma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sisomicin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of either sex and suffering from primary pyodermas requiring topical antibiotic therapy without occlusive dressings.
* \>=6 years of age.
* Written informed consent.

Exclusion Criteria

* Patients must not take any other antibiotics.
* Patients should not be hypersensitive to any of the test drugs.
* Patients are not to have any other investigational drug within one month of starting this study.
* Patients cannot be enrolled more than once in the study.
* Patients must not have any significant medical condition which, in the judgment of the investigator, might interfere with the study or require treatment.
* Pregnant women and nursing mothers are to be excluded.

Minimum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers